RNA, 7SL, cytoplasmic 282, pseudogene (RN7SL282P)

RN7SL282P is a pseudogene derived from the 7SL RNA gene. The 7SL RNA is the RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex essential for targeting proteins to the endoplasmic reticulum during translation. Pseudogenes like RN7SL282P are typically non-functional genetic elements generated by duplication or reverse transcription of parent genes; they accumulate mutations and are generally not transcribed into functional RNA. However, some pseudogenes can exert regulatory roles by acting as competitive endogenous RNAs (ceRNAs), interfering with microRNA pathways or being processed into regulatory small RNAs. There is no direct evidence or annotation that RN7SL282P produces functional RNA or protein, serves as a receptor or enzyme, or acts in a pharmaceutical or clinical context. This locus is a pseudogene, not a protein-coding gene, not a receptor, not a therapeutic target, and likely misspecified as a target. Its parent gene, 7SL RNA, functions in co-translational targeting of proteins and has documented roles in cell signaling, viral infection response, and cancer cell communication—none of which are attributed to RN7SL282P itself without further evidence. The vast majority of 7SL RNA-like loci in human DNA are pseudogenes, with no more than four being authentic functional genes. RN7SL282P is not the canonical 7SL RNA gene nor its primary pseudogene with documented functions. Its listing as a pharmacological or therapeutic target is incorrect. There is no information available about drugs, biomarkers, or disease associations specific to RN7SL282P. For detailed functional or clinical application, targets should be mapped to active, protein-coding genes or well-characterized non-coding RNAs with documented biological roles.

Other names

RN7SL282PRNA, 7SL, cytoplasmic 282, pseudogene

None known